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Summary: Different batches of bromocresol green were used in a
study of several modifications of the bromocresol green method
for serum albumin. No major batch Variation was observed. Lyo-
philized animal sera and a certain batch of lyophilized human se-
ra, however, responded differently from a pool of fresh human
sera when the method was modified. These phenomena should be
taken into account in calibration procedures and in quality assess-
merit.
Analyt- und Matrix-Probleme bei der Kalibrierung und Qualitäts-
kontrolle der Bromkresolgrüfc Methode für Albumin im Serum
Zusammenfassung: Verschiedene Chargen von Bromkresolgrün
wurden für eine Untersuchung mehrerer Modifikationen der
Bromkresolgrün-Methode für Albumin im Serum eingesetzt.
Größere Chargenunterschiede wurden nicht beobachtet. Lyophi-
lisierte Tierseren und eine bestimmte Charge lyophilisierter Seren
vom Menschen reagierten jedoch abweichend von einem Pool
frischer Seren vom Menschen auf die Modifizierung der Methode.
Diese Erscheinungen sollten 'bei der Kalibrierung und der Quali-
tätskontrolle berücksichtigt werden.
Introduction
The bromocresol green method for serum albumin is still used
extensively in many clijiical chemistry laboratories in spite of con-
siderable criticism (1). The methods might wörk properly (2—5),
but in external quality assessment the results are often poor (e.g.
I.e. (6)).
Bromocresol green is marketed äs a pH indicator, and production
control during manufacture can only be expected to cover this
type of use. Therefore it was the aim of the present paper to inves-
tigate differences between batches of bromocresol green, and to
find other possible explanations for interlaboratory Variation in
the bromocresol green method for serum albumin.
Materials and Methods
Bromocresol green
Five batches of bromocfesol green art. no. 8121 from E. Merck
(Darmstadt, West Germany) were investigated, three from the la-
boratories showing the greatest deviations in the earlier survey
(6), a 25 year-old batch and a brand new one.
Bromocresol green reagent
Appropriate concentrations of bromocresol green were prepared
fresh by dissolution of bromocresol green in an aqueous succinic
acid/succinate buffer, pH 4.2 (23 °C) (50 mmol succinate and
0.75 ml Brij™ 35 in one Ihre).
Reference sera
The following reference sera were used:
Pool of fresh sera,
lyophilized serum from bank blood (D; local production),
commercially available lyophilized serum (G; intended for gener-
al quality control, "abnormal" level, Dade^, American Hospital
Supply Corp., Miami, USA),
equine lyophilized serum (H; Nyegaard & Co., Norway),
mixed bovine-equine lyophilized serum (I; Nyegaard & Co., Nor-
way) and
a human albumin solution (Protein Standard, Kabi Diagnostica
AB, Sweden).
The materials, identified by letters, were the same äs those used in
the previous investigation (6).
Procedure
One volume of specimen was diluted with 20 volumes of aqueous
sodium Chloride (154 mmol in one litre). An aliquot (50 ul) of this
diluted sample was added to 450 bromocresol green reagent
and the absorbance of the mixture was read against water at 630
nm between 35s and 1235s after mixing in the GEMSAEC™
(Electro-Nucleonics Corp., New Jersey, USA).
Albumin was furthermore determined by a bromcresol green
method on the SMAC I™ (Technicon Instruments Corp., New
York, USA); reaction conditions: Specimen dilution l vol + 122
vol; preheated at 45 °C in 170 s; bromocresol green 135 / ;
succinic acid buffer, pH 4.2; merthiolate; Pegosperse™ 1.5 vol in
100 vol; reaction time 17s.
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Results
Table l shows the colour yield of different albumin preparations
in comparison with the lyophilized serum from bank blood (D).
Thus the data are shown in a way, similar to results obtained in a
continuous flow System using a calibration serum. No major dif-
ferences were found between different batches of bromocresol
green.
The behaviour of the fresh serum pool was similar to that of the
locaily produced lyophilized serum from bank blood (D). This is
in contrast to the albumin solution, the two animal lyophilized
sera (H and I) and the lyophilized human serum (G). The latter
contained elevated concentrations of many components, e. g. bill·
rubins.
Using the SMAC I™, the following results were obtained for the
albumin-containing materials shown in table l, in the same des-
cending order: 604 μιηοΐ/ΐ, 600 μηιοΐ/l, 455 μιηοΐ/l, 529 μιηοΐ/l
and 552 umol/1. A value of 685 umol/1 was found for the lyophil-
ized serum from bank blood (D) used s calibrator.
The bottom of table l records a lack of proportionality between
absorbance and concentration of bromocresol green in the pure
reagents.
Discussion
The big Variation of accuracy often found between laboratories
using bromocresol green methods for albumin could not be ex-
plained by batch variations of bromocresol green. Furthermore,
using high performance liquid chromatography and thin layer
chromatography the bromocresol green batches seemed quite
pure; "less than 1% of impurities" were fo hd with exception of
the 25 years old batch "where 2% was found" (K. E. Rasmussen,
H. Ravn, personal communication 1981).
The present data show th t the type of reference materials con-
tribute remarkably to the uiterlaboratory Variation, when meth-
ods with different reaction times and different concentrations of
bromocresol green are compared (2, 3); evefi different reference
materials of human origin gave different response. Ageing of rea-
gents containing Pegosperse™ have been reported s an addition-
al soufce pf error (7) s well s different salt concentration (8).
The present fmdings should be taken iiito aecount in selecting cal-
ibration materials. Pools of fresh sera should probably be used s
secondary calibration material (9).
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Tab. l. The time dependence of the colour yield of albumin preparations at different concentrations of bromocresol green in the re ctipii
mixture at 630 nm, read against reagent blank. The absorbance is expressed in percentage of that obtained simultaneously on a
lyophilized serum from bank blood (D). Each set of data represents mean values obtained on at least three batches of brorho^
cresol green (Merck art. no. 8121) from the batch numbers: 625927, 8601737,9622557,9023339 and 1153373. Batch number
9622557 showed the most variable results, and examples of these data are given for albumin in parenthesis.
Concentration of bromocresol green
Reaction time
Albumin solution
(Kabi Diagnostica AB, Sweden)
Fresh pool of human sera
Lyophilized human serum (G)
45
35
94
(94)
85
70
215
95
(95)
86
71
1235
94
(94)
87
68
35
92
(91)
84X)
66
215
89
(89)
83X)
65
1235
88
(87)
85XX)
65
135
35
83
(81)
82X)
55
215
82
(80)
84X)
56
1235
80
(77)
86X)
57
Unit
μιηοΐ/ΐ
s
%
%
%
(DADE, American hospital Suppliers Corp.
Miami)
Lyophiiized equine serum (H)
(Nyegaard AS, Norway)
Lyophilized bovine-equine serum (I)
(Nyegaard AS, Norway)
69 68
71 70 71
69 68 70
78 78 80
65 66 67 %
85X) 89X) 88") %
Absorbance r nge; lyophilized serum from
bank blood (D), read against reagent blank
Absorbance of bromocresol green reagent
read against water
0.47-0.52
0.06-0.08
0.52-0.58
0.12-0.15
0.45-0.55
0.36-0.42
1.
1
x) s for all results (3-9) were 1.0 or less if no asterisk is present. One asterisk signifies s between 1.2 and 2.0.
**) s for the 9 measurements was 3.6.
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